Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Resistance to Viread, Envitra??
Jul 11, 2009

Hi I'm newly diagnosed and recently started treatment as well. My first medication was Atripla, which after one day I had a bad reaction to so I stopped taking it. I returned to my doctor and she put me on Tuvada-Lexiva-Norvir. My question is since truvada is part of Atripla, (which I took 1 dose of, then stopped for a week), do you think that the chance that I may have developed any resistance to truvada is significant?

Response from Dr. Young

Hello and thank you for your post.

It's really unlikely that a single dose of Atripla would have caused resistance to the tenofovir/FTC parts (AKA Truvada). Hence, the regimen of Truvada+ boosted Lexiva should retain full activity.

So, be well. Let us know how you do on your new regimen.

BY



Previous
Questions
Next
monoclonal protein

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement